Pregnancy and multiple sclerosis

Mayo Clinic Proceedings

Volumn 72, Issue 10, 1997, Pages 977-989

  Damek, Denise M ^a   Shuster, Elizabeth A ^b  

^a MAYO CLINIC   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AZATHIOPRINE; BACLOFEN; BETA1 INTERFERON; CARBAMAZEPINE; CLADRIBINE; COPOLYMER; CORTICOSTEROID; INTERFERON BETA SERINE; METHOTREXATE; OXYBUTYNIN; PEMOLINE; TIZANIDINE;

CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; ORAL CONTRACEPTION; PREGNANCY; PRENATAL DRUG EXPOSURE; RECURRENCE RISK; TERATOGENICITY;

EID: 0030856815     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.10.977     Document Type: Conference Paper

References (78)

1. Gowers WR. Diseases of the Nervous System. Vol.2. 2nd ed. Philadelphia: P Blakeston; 1901. p 545
2. Tillman AJB. The effect of pregnancy on multiple sclerosis and its management. Proc Assoc Res Nerv Ment Dis 1950;28:548-582
3. McAlpine D, Compston N. Some aspects of natural history of disseminated sclerosis: incidence, course, and prognosis; factors affecting onset and course. Q J Med 1952;21:135167
4. SweeneyWJ. Pregnancy and multiple sclerosis. Am J Obstet Gynecol 1953;66:124-130
5. Schapira K, Poskanzer DC, Newell DJ, Miller H. Marriage, pregnancy and multiple sclerosis. Brain 1966;89:419-428
6. Millar JHD, Allison RS, Cheeseman EA, Merrett JD. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959;82:417-426
7. Ghezzi A, Caputo D. Pregnancy: a factor influencing the course of multiple sclerosis? Eur Neurol 1981;20:115-117
8. Poser S, Poser W. Multiple sclerosis and gestation. Neurology 1983;33:1422-1427
9. Korn-Lubetzki I, Kahana E, Cooper G, Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 1984; 16:229-231
10. Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 1988;259:3441-3443
11. Frith JA, McLeod JG. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 1988;51:495-498
12. Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 1990;47:738-742
13. Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand 1991;84:403-406
14. Roullet E, Verdier-Taillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry 1993;56:1062-1065
15. HutchinsonM. Pregnancy in multiple sclerosis [editorial]. J Neurol Neurosurg Psychiatry 1993;56:1043-1045
16. Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis-a 3-year prospective study. J Neurol 1994;241:228-233
17. Sadovnick AD, Eisen K, Hashimoto SA, Farquhar R, Yee IM, Hooge J, et al. Pregnancy and multiple sclerosis: a prospective study. Arch Neurol 1994;51:1120-1124
18. Rudick RA. Pregnancy and multiple sclerosis [letter] Arch Neurol 1995;52:849-850
19. Cook SD, Troiano R, Bansil S, Dowling PC. Multiple sclerosis and pregnancy. In: DevinskyO, Feldmann E, Hainline B, editors. Neurological Complications of Pregnancy. New York: Raven Press; 1994. pp 83-95
20. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995;! 18:253-261
21. Duquette P, Girard M. Hormonal factors in susceptibility to multiple sclerosis. Curr Opin Neurol Neurosurg 1993;6:195201
22. Birk K, Rudick R. Pregnancy and multiple sclerosis. Arch Neurol 1986;43:719-726
23. Abramsky O. Pregnancy and multiple sclerosis. Ann Neurol 1994;36(Suppl):S38-S41
24. Poser CM. MS and postpartum stress [letter]. Neurology 1984;34:704-705
25. Davis RK, Maslow AS. Multiple sclerosis in pregnancy: a review. Obstet Gynecol Surv 1992;47:290-296
26. Tilley BC, Barnes AB, Bergstralh E, Labarthe D, Noller KL, Colton T, et al. A comparison of pregnancy history recall and medical records: implications for retrospective studies. Am J Epidemiol 1985; 121:269-281
27. Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. AnnNYAcadSci 1965;122:552-568
28. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
29. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of followup. Brain 1993;! 16:117-134
30. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carrière W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;! 12:1419-1428
31. Weinshenker BG, Ebers GC. The natural history of multiple sclerosis. Can J Neurol Sei 1987; 14:255-261
32. Weinshenker BG, Rice GP, Noseworthy JH, Carrière W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;!14:1045-1056
33. Amato MP, Fratiglioni L, Groppi C, Siracusa G, Amaducci L. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 1988;45:746-748
34. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC (Canadian Cooperative MS Study Group). Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Neurology 1990;40:971-975
35. Francis DA, Bain P, Swan AV, Hughes RA. An assessment of disability rating scales used in multiple sclerosis. Arch Neurol 1991;48:299-301
36. Goodkin DE, Cookfair D, Wende K, Bourdette D, Pullicino P, Scherokman B, et al (Multiple Sclerosis Collaborative Research Group). Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Neurology 1992;42:859-863
37. Millar JH, Vas CJ, Noronha MJ, Liversedge LA, Rawson MD. Long-term treatment of multiple sclerosis with corticotrophin. Lancet 1967;2:429-431
38. Isaac C, Li DK, Genton M, Jardine C, Grochowski E, Palmer M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988;38:1511-1515
39. Koopmans RA, Li DK, Oger JJ, Mayo J, Paty DW. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989;39:959-963
40. Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989;25:43-49
41. van Walderveen MA, Tas MW, Barkhof F, Polman CH, Frequin ST, Hommes OR, et al. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 1994;44:327-329
42. Weinreb HJ. Demyelinating and neoplastic diseases in pregnancy. Neurol Clin 1994 Äug; 12:509-526
43. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988;29:533541
44. Sadovnick AD. Genetic epidemiology of multiple sclerosis: a survey. Ann Neurol 1994;36(Suppl 2):S194-S203
45. Thompson DS, Nelson LM, Burns A, Burks JS, Franklin GM. The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 1986;36:1097-1099
46. Weinshenker BG, Hader W, Carrière W, Baskerville J, Ebers GC. The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 1989;39:1438-1440
47. Verdru P, Theys P, D'Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 1994;96:38-41
48. Stenager E, Stenager EN, Jensen K. Effect of pregnancy on the prognosis for multiple sclerosis: a 5-year follow up investigation. Acta Neurol Scand 1994;90:305-308
49. Villard-Mackintosh L, Vessey MP. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 1993;47:161-168
50. HuntJS. Immunobiology of pregnancy. Curr Opin Immunol 1992;4:591-596
51. Hegde UC. Immunomodulation of the mother during pregnancy. Med Hypotheses 1991;35:159-164
52. Abramsky O, Brenner T, Mizrachi R, Soffer D. Alphafetoprotein suppresses experimental allergic encephalomyelitis. J Neuroimmunol 1982;2:l-7
53. Abramsky O, Soffer D, Brenner T. Prevention and treatment of experimental allergic encephalomyelitis by alpha-fetoprotein [abstract]. Neurology 1980;30:446
54. Brenner T, Evron S, Abramsky O. Effect of experimental autoimmune encephalomyelitis on pregnancy: studies in rabbits and rats. IsrJMedSci 1991;27:181-185
55. Keith AB. Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats. J Neurol Sei 1978;38:317-326
56. Greig ME, Gibbons AJ, Elliott GA. A comparison of the effects of melengestrol acetate and hydrocortisone acetate on experimental allergic encephalomyelitis in rats. J Pharmacol ExpTher 1970:173:85-93
57. Arnason BG, Richman DP. Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol 1969; 21:103-108
58. Blalock JE. The immune system as a sensory organ. J Immunol 1984; 132:1067-1070
59. Dantzer R, Kelley KW. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sei 1989;44:1995-2008
60. Weigent DA, Blalock JE. Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev 1987:100:79-108
61. Wegmann TG, Ein H, Guilbert E, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a T 2 phenomenon? Immunol Today 1993;14:353-356
62. Schuurs AH, Verheul HA. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990:35:157172
63. Nelson JE, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HEA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. NEnglJMed 1993:329:466-471
64. Gill TJ III. Maternal-fetal interactions and disease [editorial]. NEnglJMed 1993;329:500-501
65. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology. 2nd ed. Philadelphia: Saunders; 1994. p 254
66. Altman DJ. Schneider SL, Thompson DA, Cheng HL, Tomasi TB. A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus. J Exp Med 1990:172:1391-1401
67. Dayal A, Ismail MA, Jensen M, Lledo A, Arnason BGW. Pregnancy plasma inhibits interferon gamma-secreting cells in multiple sclerosis [abstract]. Neurology 1995;45(Suppl 4):A197
68. Link J, Soderstrom M, Olsson T, Hojeberg B, Ljungdahl A, Link H. Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. AnnNeurol 1994;36:379-386
69. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 1995;45(Suppl6):Sll-S15
70. Sharief MK, Thompson EJ. In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 1992:38:27-33
71. Sharief MK, Hentges R. Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis. NEnglJMed 1991:325:467-472
72. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 1992:40:619-637
73. Lahita RG. Sex hormones and the immune system. Part 1. Human data. Baillieres Clin Rheumatol 1990:4:1-12
74. Ahmed SA. Talal N. Sex hormones and the immune system. Part 2. Animal data. Baillieres Clin Rheumatol 1990:4:1331
75. Poser S, Raun NE, Wikstrom J, Poser W. Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 1979:59:108-118
76. Division of Drugs and Toxicology, American Medical Association. Drug Evaluations Annual 1995. Milwaukee: American Medical Association; 1995
77. Johnson KP. Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, et al (Copolymer 1 Multiple Sclerosis Study Group). Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 1995:45:1268-1276
78. Percy AK, Nobrega FT, Okazaki H, Glattre E, Kurland LT. Multiple sclerosis in Rochester. Minn: a 60-year appraisal. Arch Neurol 1971:25:105-111